Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-029448
Filing Date
2024-07-29
Accepted
2024-07-29 17:07:29
Documents
45
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 990210
2 ex31.htm EX-31 19515
3 ex32.htm EX-32 7405
  Complete submission text file 0001493152-24-029448.txt   4301624

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE clcs-20240331.xsd EX-101.SCH 27691
5 XBRL CALCULATION FILE clcs-20240331_cal.xml EX-101.CAL 33141
6 XBRL DEFINITION FILE clcs-20240331_def.xml EX-101.DEF 212903
7 XBRL LABEL FILE clcs-20240331_lab.xml EX-101.LAB 258258
8 XBRL PRESENTATION FILE clcs-20240331_pre.xml EX-101.PRE 233182
48 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 554721
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 241153278
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)